Birla Fertility & IVF to Invest INR 500 Cr in South India Expansion

Birla Fertility & IVF is a part of the $2.9 billion C K Birla Group, which operates 30 centers across the country.

Birla Fertility & IVF, a company under the $3-billion CK Birla Group, has planned to invest INR 500 Cr over the next 2-3 years to expand its presence in India’s rapidly growing fertility market.

Currently the third-largest fertility chain in the country, the company aims to strengthen its footprint by establishing 10-12 new centers across Karnataka, Tamil Nadu, Kerala, Telangana, and Andhra Pradesh within the next 12-24 months.

Birla Fertility & IVF is a part of the $2.9 billion C K Birla Group, which operates 30 centers across the country.

Expansion into Tier II & Tier III Cities

The strategic investment is part of the company’s broader vision to capture a larger share of the domestic IVF market by focusing on Tier II and Tier III cities.

"The group is viewing for a bigger share of the IVF market and plans to invest INR 500 Cr in the next 2-3 years," the company said in a statement.

Avanti Birla, Chairman and Founder of Birla Fertility & IVF, emphasized the company’s commitment to providing advanced fertility solutions to a wider audience by investing heavily in infrastructure and leveraging its expertise.

Acquisitions Bolster Network

In a significant move to enhance its presence, Birla Fertility & IVF recently acquired two fertility clinic chains, BabyScience, and ARMC IVF, bringing its network to a total of 50 clinics across India.

The acquisition includes 12 BabyScience clinics located primarily in Karnataka, Maharashtra, and Tamil Nadu, further solidifying the company’s position in southern and western India.

Abhishek Aggrawal, chief business officer at Birla Fertility & IVF, highlighted the company’s expansion strategy, which includes a mix of organic growth, further acquisitions, and strategic partnerships.

The company has set an ambitious target of establishing 100 clinics by FY28, aiming to deliver exceptional pregnancy rates that align with international standards.

This expansion is expected to significantly boost the company’s presence and influence in the Indian fertility market.

Growing Relevance of IVFs

In India, more than 28 million couples are dealing with fertility issues, yet fewer than 1% are seeking help. The expansion of the IVF sector will be fueled by increased understanding and improved access to top-tier treatments across the country.

Last year, Indira IVF, partnered with SafeTree, a leading insurtech, to launch India’s first insurance to support couples with infertility.

The insurance offers a proactive approach for the first 24 months with medical, dietary, and psychological consultations to help couples under the age of 35 years conceive naturally.

This initiative aims to uplift healthcare delivery in the country by helping couples make significant savings in their standalone treatment cost.